MicroRNA‐30d and ‐483‐3p for bi‐ventricular remodelling and miR‐126‐3p for pulmonary hypertension in advanced heart failure
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA‐30d and ‐483‐3p for bi‐ventricular remodelling and miR‐126‐3p for pulmonary hypertension in advanced heart failure
Authors
Keywords
-
Journal
ESC Heart Failure
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-21
DOI
10.1002/ehf2.14546
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global burden of heart failure: a comprehensive and updated review of epidemiology
- (2022) Gianluigi Savarese et al. CARDIOVASCULAR RESEARCH
- Micro RNA ‐483 amelioration of experimental pulmonary hypertension
- (2020) Jin Zhang et al. EMBO Molecular Medicine
- The microRNA in ventricular remodeling: the miR-30 family
- (2019) Xiaonan Zhang et al. BIOSCIENCE REPORTS
- Relations between circulating microRNAs (miR-21, miR-26, miR-29, miR-30 and miR-133a), extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy
- (2017) Paweł Rubiś et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy
- (2017) Lei Lai et al. LIFE SCIENCES
- The miR-30 family: Versatile players in breast cancer
- (2017) Su-Jin Yang et al. TUMOR BIOLOGY
- MiR30‐GALNT1/2 Axis‐Mediated Glycosylation Contributes to the Increased Secretion of Inactive Human Prohormone for Brain Natriuretic Peptide (proBNP) From Failing Hearts
- (2017) Yasuaki Nakagawa et al. Journal of the American Heart Association
- MicroRNA-328, a Potential Anti-Fibrotic Target in Cardiac Interstitial Fibrosis
- (2016) Weijie Du et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease
- (2016) Dimitry A. Chistiakov et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study
- (2015) Y. F. Melman et al. CIRCULATION
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2015) Roberto M. Lang et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity
- (2015) J-X Wang et al. Cell Death & Disease
- Identification of cardiac-related circulating microRNA profile in human chronic heart failure
- (2015) Huaping Li et al. Oncotarget
- MicroRNAs in Heart Failure
- (2014) Yonathan F. Melman et al. Circulation-Heart Failure
- Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device
- (2014) Andrew C. Morley-Smith et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiomyocyte-Specific miRNA-30c Over-Expression Causes Dilated Cardiomyopathy
- (2014) Wino J. Wijnen et al. PLoS One
- MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors
- (2013) Jayavarshni Ganesan et al. CIRCULATION
- Non-cardiomyocyte microRNAs in heart failure
- (2011) A. J. Tijsen et al. CARDIOVASCULAR RESEARCH
- MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation
- (2010) Yanjie Lu et al. CIRCULATION
- Method agreement analysis: A review of correct methodology
- (2010) P.F. Watson et al. THERIOGENOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More